A Study Of PF-05280014 [Trastuzumab-Pfizer] Or Herceptin® [Trastuzumab-EU] Plus Paclitaxel In HER2 Positive First Line Metastatic Breast Cancer Treatment (REFLECTIONS B327-02)
Clinical trial NCT01989676 · COMPLETED
Trial details
- NCT number
- NCT01989676
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-24
- Primary completion
- 2016-08-24
- Enrollment
- 707
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.